Wave Life Sciences (WVE) EBIT Margin: 2015-2025
Historic EBIT Margin for Wave Life Sciences (WVE) over the last 7 years, with Jun 2025 value amounting to -606.49%.
- Wave Life Sciences' EBIT Margin fell 42877.00% to -606.49% in Q2 2025 from the same period last year, while for Jun 2025 it was -286.43%, marking a year-over-year decrease of 21069.00%. This contributed to the annual value of -101.94% for FY2024, which is 4193.00% down from last year.
- Wave Life Sciences' EBIT Margin amounted to -606.49% in Q2 2025, which was down 11.73% from -542.82% recorded in Q1 2025.
- In the past 5 years, Wave Life Sciences' EBIT Margin ranged from a high of 9.03% in Q3 2023 and a low of -13,648.77% during Q3 2022.
- Over the past 3 years, Wave Life Sciences' median EBIT Margin value was -205.98% (recorded in 2023), while the average stood at -249.69%.
- Its EBIT Margin has fluctuated over the past 5 years, first tumbled by 1,362,789bps in 2022, then skyrocketed by 1,365,780bps in 2023.
- Wave Life Sciences' EBIT Margin (Quarterly) stood at -2,045.89% in 2021, then plummeted by 147,009bps to -3,515.98% in 2022, then soared by 345,168bps to -64.30% in 2023, then slumped by 7,154bps to -177.72% in 2024, then tumbled by 42,877bps to -606.49% in 2025.
- Its last three reported values are -606.49% in Q2 2025, -542.82% for Q1 2025, and -177.72% during Q2 2024.